Rituximab failed to improve survival after stem cell transplant for DLBCL Healio Patients with diffuse large B-cell lymphoma who were treated with rituximab after autologous stem cell transplantation experienced similar outcomes as those in an observation group, according to study results. Researchers conducted the investigation to ... |
